When you get a moment, the following from the June 2016 Magellan Global Investor Report provides a valuable insight into the future.
Data generation, collection, analysis and monetisation is clearly a major element in all the key pillars of the emerging technolgical revolution, providing Buddy with an oustanding opportunity, and not an FDA approval in sight!